iMetabolic Biopharma
Growth Stage
Bringing Hope to Communities Through Tech-Powered Biopharma.
Overview
Raised: $246,816
Total Commitments ($USD)
Platform
StartEngine
Start Date
12/19/2022
Close Date
03/16/2023
Min. Goal
$10,000
Max. Goal
$1,230,000
Min. Investment
$250
Security Type
Convertible Note
Series
Seed
Funding Type
RegCF
Valuation Cap
$25,000,000
Discount Rate
10%
Rolling Commitments ($USD)
Status
Active
Reporting Date
02/01/2023
Days Remaining
43
% of Min. Goal
2,468%
% of Max. Goal
20%
Likelihood of Max
Avg. Daily Raise
$5,609
# of Investors
205
Momentum
Create a free account today to gain access to KingsCrowd analytics.
Location
Tempe, Arizona
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Distribution Model
B2B
Margin
Medium
Capital Intensity
High
IMetabolic Biopharma, with a valuation of $25 million, is raising funds on StartEngine. It is an early-stage drug discovery company developing new, life-saving drugs to fight against some of today's most devastating chronic diseases. IMetabolic Biopharma technology-powered iPlatform™ pipeline removes the roadblocks that typically make drug development slow, expensive, and inefficient. Currently the company is pre-market. Urban Austin Kiernan founded the company in 2017. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1,230,000. The campaign proceeds will be used for Therapeutic asset research and development, software research and development, executive compensation and working capital.
Summary Profit and Loss Statement
| Most Recent Year | Prior Year | |
|---|---|---|
|
Revenue |
$0 |
$0 |
|
COGS |
$0 |
$0 |
|
Tax |
$0 |
$0 |
| ||
| ||
|
Net Income |
$-63,745 |
$-22,130 |
Summary Balance Sheet
| Most Recent Year | Prior Year | |
|---|---|---|
|
Cash |
$64,248 |
$119,176 |
|
Accounts Receivable |
$0 |
$0 |
|
Total Assets |
$64,248 |
$119,176 |
|
Short-Term Debt |
$17,192 |
$3,139 |
|
Long-Term Debt |
$139,336 |
$148,000 |
|
Total Liabilities |
$156,528 |
$151,139 |
Financials as of: 12/19/2022
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$12.42 /month
billed annually - Free portfolio tracking and KingsCrowd's quantitative ratings on all raises.
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings (excluding risk)
- Advanced company search ( with ratings)
- Markets page filters and historical industry data
- Get Edge Annual
Edge
-
$41.58 /month
billed annually - Full site access including KingsCrowd's qualitative analyst reports.
- Plan Includes:
- Everything in Edge, plus
- Full access to detailed Analyst Reports (e.g. Top Deal, Deal to Watch, Neutral, and Underweight)
- Search and filter based on Analyst Reports
- In-depth risk ratings for every raise
- Get Edge Pro Annual
Edge Pro
Already a member? Log in here.
Ratings 
